🇦🇺 Arcapta Neohaler in Australia

Arcapta Neohaler (INDACATEROL) regulatory status in Australia.

Marketing authorisation

TGA

  • Status: likely_approved

Arcapta Neohaler in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Respiratory approved in Australia

Frequently asked questions

Is Arcapta Neohaler approved in Australia?

Yes. TGA has authorised it.

Who is the marketing authorisation holder for Arcapta Neohaler in Australia?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.